BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 11731618)

  • 21. Signal transducers and activators of transcription as downstream targets of nongenomic estrogen receptor actions.
    Björnström L; Sjöberg M
    Mol Endocrinol; 2002 Oct; 16(10):2202-14. PubMed ID: 12351686
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dominant negative variants of the SHP-2 tyrosine phosphatase inhibit prolactin activation of Jak2 (janus kinase 2) and induction of Stat5 (signal transducer and activator of transcription 5)-dependent transcription.
    Berchtold S; Volarevic S; Moriggl R; Mercep M; Groner B
    Mol Endocrinol; 1998 Apr; 12(4):556-67. PubMed ID: 9544991
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A nuclear protein tyrosine phosphatase TC-PTP is a potential negative regulator of the PRL-mediated signaling pathway: dephosphorylation and deactivation of signal transducer and activator of transcription 5a and 5b by TC-PTP in nucleus.
    Aoki N; Matsuda T
    Mol Endocrinol; 2002 Jan; 16(1):58-69. PubMed ID: 11773439
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cloning and expression of Stat5 and an additional homologue (Stat5b) involved in prolactin signal transduction in mouse mammary tissue.
    Liu X; Robinson GW; Gouilleux F; Groner B; Hennighausen L
    Proc Natl Acad Sci U S A; 1995 Sep; 92(19):8831-5. PubMed ID: 7568026
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Progesterone receptor repression of prolactin/signal transducer and activator of transcription 5-mediated transcription of the beta-casein gene in mammary epithelial cells.
    Buser AC; Gass-Handel EK; Wyszomierski SL; Doppler W; Leonhardt SA; Schaack J; Rosen JM; Watkin H; Anderson SM; Edwards DP
    Mol Endocrinol; 2007 Jan; 21(1):106-25. PubMed ID: 16973758
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interleukin-2 inhibits glucocorticoid receptor transcriptional activity through a mechanism involving STAT5 (signal transducer and activator of transcription 5) but not AP-1.
    Biola A; Lefebvre P; Perrin-Wolff M; Sturm M; Bertoglio J; Pallardy M
    Mol Endocrinol; 2001 Jul; 15(7):1062-76. PubMed ID: 11435608
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Two tandemly linked interferon-gamma-activated sequence elements in the promoter of glycosylation-dependent cell adhesion molecule 1 gene synergistically respond to prolactin in mouse mammary epithelial cells.
    Hou Z; Srivastava S; Mistry MJ; Herbst MP; Bailey JP; Horseman ND
    Mol Endocrinol; 2003 Oct; 17(10):1910-20. PubMed ID: 12869589
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decidual prolactin silences the expression of genes detrimental to pregnancy.
    Bao L; Tessier C; Prigent-Tessier A; Li F; Buzzio OL; Callegari EA; Horseman ND; Gibori G
    Endocrinology; 2007 May; 148(5):2326-34. PubMed ID: 17255200
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An immunohistochemical approach to monitor the prolactin-induced activation of the JAK2/STAT5 pathway in pancreatic islets of Langerhans.
    Brelje TC; Svensson AM; Stout LE; Bhagroo NV; Sorenson RL
    J Histochem Cytochem; 2002 Mar; 50(3):365-83. PubMed ID: 11850439
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of the intronic promoter of rat estrogen receptor alpha gene, responsible for truncated estrogen receptor product-1 expression.
    Schausi D; Tiffoche C; Thieulant ML
    Endocrinology; 2003 Jul; 144(7):2845-55. PubMed ID: 12810539
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prolactin-induced activation and binding of stat proteins to the IL-6RE of the alpha 2-macroglobulin (alpha 2M) promoter: relation to the expression of alpha 2M in the rat ovary.
    Russell DL; Norman RL; Dajee M; Liu X; Hennighausen L; Richards JS
    Biol Reprod; 1996 Nov; 55(5):1029-38. PubMed ID: 8902214
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A sequence of the CIS gene promoter interacts preferentially with two associated STAT5A dimers: a distinct biochemical difference between STAT5A and STAT5B.
    Verdier F; Rabionet R; Gouilleux F; Beisenherz-Huss C; Varlet P; Muller O; Mayeux P; Lacombe C; Gisselbrecht S; Chretien S
    Mol Cell Biol; 1998 Oct; 18(10):5852-60. PubMed ID: 9742102
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estrogens activate bone morphogenetic protein-2 gene transcription in mouse mesenchymal stem cells.
    Zhou S; Turgeman G; Harris SE; Leitman DC; Komm BS; Bodine PV; Gazit D
    Mol Endocrinol; 2003 Jan; 17(1):56-66. PubMed ID: 12511606
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Growth hormone, but not prolactin, maintains, low-level activation of STAT5a and STAT5b in female rat liver.
    Choi HK; Waxman DJ
    Endocrinology; 1999 Nov; 140(11):5126-35. PubMed ID: 10537141
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Distinctive roles for prolactin and growth hormone in the activation of signal transducer and activator of transcription 5 in pancreatic islets of langerhans.
    Brelje TC; Stout LE; Bhagroo NV; Sorenson RL
    Endocrinology; 2004 Sep; 145(9):4162-75. PubMed ID: 15142985
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Naturally occurring dominant-negative Stat5 suppresses transcriptional activity of estrogen receptors and induces apoptosis in T47D breast cancer cells.
    Yamashita H; Iwase H; Toyama T; Fujii Y
    Oncogene; 2003 Mar; 22(11):1638-52. PubMed ID: 12642867
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cross-talk between signal transducer and activator of transcription (Stat5) and thyroid hormone receptor-beta 1 (TRbeta1) signaling pathways.
    Favre-Young H; Dif F; Roussille F; Demeneix BA; Kelly PA; Edery M; de Luze A
    Mol Endocrinol; 2000 Sep; 14(9):1411-24. PubMed ID: 10976919
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Growth hormone- and prolactin-induced proliferation of insulinoma cells, INS-1, depends on activation of STAT5 (signal transducer and activator of transcription 5).
    Friedrichsen BN; Galsgaard ED; Nielsen JH; Møldrup A
    Mol Endocrinol; 2001 Jan; 15(1):136-48. PubMed ID: 11145745
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Down-regulation of STAT5b transcriptional activity by ligand-activated peroxisome proliferator-activated receptor (PPAR) alpha and PPARgamma.
    Shipley JM; Waxman DJ
    Mol Pharmacol; 2003 Aug; 64(2):355-64. PubMed ID: 12869640
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential expression of the estrogen receptors alpha and beta in the rat corpus luteum of pregnancy: regulation by prolactin and placental lactogens.
    Telleria CM; Zhong L; Deb S; Srivastava RK; Park KS; Sugino N; Park-Sarge OK; Gibori G
    Endocrinology; 1998 May; 139(5):2432-42. PubMed ID: 9564855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.